Related Experiment Video
Updated: May 6, 2026

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
Published on: October 28, 2020
Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart
M J Lenzen1, W J M Scholte op Reimer, E Boersma
1Department of Cardiology, Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands.
Insights
Heart failure patients with preserved left ventricular function (PLVF) are older, more likely women, and have higher rates of hypertension and atrial fibrillation. Despite clinical differences, mortality remains high in both PLVF and left ventricular systolic dysfunction (LVSD) groups.
Area of Science:
- Cardiology
- Heart Failure Research
Background:
- Limited clinical trials exist for managing chronic heart failure with preserved left ventricular function (PLVF).
- The EuroHeart Failure Survey offers insights into PLVF patient characteristics, treatment, and outcomes compared to left ventricular systolic dysfunction (LVSD).
Purpose of the Study:
- To compare the characteristics, treatment, and outcomes of patients with PLVF versus LVSD using EuroHeart Failure Survey data.
- To investigate potential differences in mortality predictors and treatment effects between PLVF and LVSD cohorts.
Main Methods:
- Secondary analysis of 6806 patients from the EuroHeart Failure Survey with measured LV function.
- Categorization into two groups: LVSD (54%) and PLVF (46%).
- Multivariate analysis to identify independent predictors of mortality and assess treatment effects.
Main Results:
- PLVF patients were older, predominantly women, and more frequently had hypertension and atrial fibrillation than LVSD patients.
- PLVF patients received less cardiovascular medication, excluding calcium antagonists.
- LVSD was an independent predictor of mortality, but no significant difference in treatment effects on mortality was observed between the groups.
Conclusions:
- A substantial proportion of heart failure patients in the survey exhibited PLVF.
- Significant clinical disparities exist between PLVF and LVSD patient groups.
- Both PLVF and LVSD are associated with high morbidity and mortality rates.
Aims:
Due to a lack of clinical trials, scientific evidence regarding the management of patients with chronic heart failure and preserved left ventricular function (PLVF) is scarce. The EuroHeart Failure Survey provided information on the characteristics, treatment and outcomes of patients with PLVF as compared to patients with a left ventricular systolic dysfunction (LVSD).
Methods And Results:
We performed a secondary analysis using data from the EuroHeart Failure Survey, only including patients with a measurement of LV function (n = 6806). We selected two groups: patients with LVSD (54%) and patients with a PLVF (46%). Patients with a PLVF were, on average, 4 years older and more often women (55% vs. 29%, respectively, p < 0.001) as compared to LVSD patients, and were more likely to have hypertension (59% vs. 50%, p < 0.001) and atrial fibrillation (25% vs. 23%, p = 0.01). PLVF patients received less cardiovascular medication compared to PLVF patients, with the exception of calcium antagonists. Multivariate analysis revealed that LVSD was an independent predictor for mortality, while no differences in treatment effect on mortality between the two groups was observed. A sensitivity analysis, using different thresholds to separate patients with and without LVSD revealed comparable findings.
Conclusions:
In the EuroHeart Failure Survey, a high percentage of heart failure patients had PLVF. Although major clinical differences were seen between the groups, morbidity and mortality was high in both groups.
Related Concept Videos
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Heart Failure III: Clinical Manifestations
Heart Failure IV: Classification and Diagnostic Evaluation

